Insider Trading March 18, 2026

Waters Corp Director Wei Jiang Acquires $144,730 in Shares Amid Integration Moves

Director purchase coincides with debt issuance and analyst reassessments as company integrates recent SpinCo acquisition

By Maya Rios WAT
Waters Corp Director Wei Jiang Acquires $144,730 in Shares Amid Integration Moves
WAT

Waters Corp director Wei Jiang purchased 500 shares on March 16, 2026, for $289.46 each, a $144,730 transaction that brings his direct holdings to 3,441.27 shares. The insider buy occurs while the stock trades near its 52-week low and after the company priced $3.5 billion of senior notes tied to the SpinCo acquisition; analysts have adjusted price targets and flagged integration and execution risks.

Key Points

  • Director Wei Jiang purchased 500 shares on March 16, 2026, for $289.46 each, totaling $144,730 and raising his direct holdings to 3,441.27 shares.
  • Waters Corp has priced a $3.5 billion senior notes offering through Augusta SpinCo Corporation across five tranches, tied to activity after acquiring the SpinCo Business from Becton, Dickinson and Company.
  • Analysts including Stifel, UBS and TD Cowen have adjusted price targets and maintained Hold/Neutral stances, citing software transition challenges, execution risks with the recent acquisition, and related performance issues.

Director Wei Jiang of Waters Corporation executed an insider purchase on March 16, 2026, acquiring 500 shares of the company’s common stock at $289.46 per share. The purchase totaled $144,730 and increases Jiang’s direct ownership to 3,441.27 shares.

The transaction takes place as Waters Corp shares trade close to a 52-week low of $275.05 and sit down 22% year-to-date. Third-party valuation commentary from InvestingPro indicates Waters appears slightly overvalued relative to its Fair Value and the platform lists 13 additional ProTips for the WAT ticker, offering further financial and market observations.


Concurrent corporate financing and reporting actions provide additional context for the insider purchase. Waters Corporation priced a $3.5 billion senior notes offering through its subsidiary Augusta SpinCo Corporation. The offering was structured across five tranches with differing maturities and interest rates. Company disclosures indicate this financing is part of broader activity following its acquisition of Becton, Dickinson and Company’s former Biosciences and Diagnostic Solutions business, referred to in filings as the SpinCo Business.

Waters Corporation filed an 8-K with the Securities and Exchange Commission that includes unaudited financial statements for the acquired business. Those unaudited statements will be included in a forthcoming registration statement on Form S-3.

Market analysts have updated their views in response to the company’s recent developments. Stifel has kept a Hold rating on the stock with a $380 price target, noting challenges related to software transitions that are affecting customer relationships. UBS trimmed its price target from $395 to $370 while maintaining a Neutral rating, citing execution risks tied to the recent acquisition. TD Cowen lowered its target to $373 from $400 after observing the decline in Waters Corp’s share price and pointing to weak performance at Becton Dickinson.

These analyst actions, the sizeable debt issuance, and the disclosure of unaudited SpinCo financials reflect ongoing adjustments and evaluations as Waters integrates the acquired business. Observers and stakeholders will be monitoring how the integration progresses alongside the company’s capital structure decisions.


Summary of the transaction:

  • Insider: Director Wei Jiang
  • Shares purchased: 500
  • Price per share: $289.46
  • Total value: $144,730
  • Date: March 16, 2026
  • Post-transaction direct holdings: 3,441.27 shares

Contextual developments:

  • Waters priced $3.5 billion in senior notes via Augusta SpinCo Corporation across five tranches.
  • Filed an 8-K with unaudited financial statements for the SpinCo Business for inclusion in a forthcoming Form S-3 registration statement.
  • Analyst price target adjustments from Stifel, UBS, and TD Cowen reflect integration and execution concerns.

Risks

  • Execution risk tied to integrating the SpinCo Business, as noted by analysts - affects corporate performance and customer relations in the life sciences and diagnostics sector.
  • Market valuation and near-term share price volatility - the stock trades near its 52-week low and is down 22% year-to-date, posing liquidity and market sentiment risks for investors.
  • Debt load and capital structure considerations following the $3.5 billion senior notes offering - increased leverage could influence credit metrics and balance sheet flexibility for the company.

More from Insider Trading

Major stakeholder increases Mission Produce holdings amid recent weakness Mar 18, 2026 Universal Technical Director Sells $182,938 in UTI Stock as Shares Trade Near 52-Week High Mar 18, 2026 Blackstone Mortgage Trust CFO Disposes of 452 Shares as Company Reports Q4 2025 Results Mar 18, 2026 Synaptics Legal Chief Executes Planned Sale; Company Posts Q2 Beat but Shares Slip After Hours Mar 18, 2026 Kratos Corporate Controller Disposes of $559,844 in KTOS Shares; Company Activity Continues Amid Defense Contracts and Equity Offer Mar 18, 2026